日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Systemic Mastocytosis, KIT and the Effects of KIT Tyrosine Kinase Inhibitors on Mast Cell and Basophil Activation

系统性肥大细胞增多症、KIT 以及 KIT 酪氨酸激酶抑制剂对肥大细胞和嗜碱性粒细胞活化的影响

Valent, Peter; Hartmann, Karin; Stefanzl, Gabriele; Filik, Yüksel; Bauer, Karin; Degenfeld-Schonburg, Lina; Gleixner, Karoline V; Siebenhaar, Frank; Niedoszytko, Marek; Sperr, Wolfgang R; Aghaallaei, Narges; Hoermann, Gregor; Sabato, Vito; Orfao, Alberto; Arock, Michel; Akin, Cem

Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation

肠道REG3凝集素通过减少黏膜相关微生物群和阻止细菌移位来预防酒精性脂肪性肝炎

Wang, Lirui; Fouts, Derrick E; Stärkel, Peter; Hartmann, Phillipp; Chen, Peng; Llorente, Cristina; DePew, Jessica; Moncera, Kelvin; Ho, Samuel B; Brenner, David A; Hooper, Lora V; Schnabl, Bernd

Evolution of mast cell research associated with the Laboratory of Allergic Diseases, 1985-2022: Summary of the 2023 NIAID Symposium

1985-2022年与过敏性疾病实验室相关的肥大细胞研究发展历程:2023年NIAID研讨会总结

Komarow, Hirsh D; Nilsson, Gunnar; Okayama, Yoshimichi; Mekori, Yoseph; Olivera, Ana; Valent, Peter; Hartmann, Karin; Brockow, Knut; Cruse, Glenn; Lyons, Jonathan; Klion, Amy D; Akin, Cem; Gotlib, Jason R; Castells, Mariana; Galli, Stephen J; Metcalfe, Dean D; Carter, Melody C

Serum Levels of Candida albicans 65-kDa Mannoprotein (CaMp65p) Correlate with Liver Disease in Patients with Alcohol Use Disorder

酒精使用障碍患者血清中白色念珠菌65 kDa甘露糖蛋白(CaMp65p)水平与肝脏疾病相关

Schnabl, Julia T; Sandini, Silvia; Stärkel, Peter; Hartmann, Phillipp

Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphoma

经典霍奇金淋巴瘤中克隆扩增的淋巴结浸润T细胞的免疫表型和检查点分子表达

Ballhausen, Alexej; Ben Hamza, Amin; Welters, Carlotta; Dietze, Kerstin; Bullinger, Lars; Rahn, Hans-Peter; Hartmann, Sylvia; Hansmann, Martin-Leo; Hansmann, Leo

Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022

肥大细胞活化综合征:国际过敏学会2022年最新进展

Valent, Peter; Hartmann, Karin; Bonadonna, Patrizia; Niedoszytko, Marek; Triggiani, Massimo; Arock, Michel; Brockow, Knut

Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta

Ifitm5/BRIL p.S42 敲入小鼠生长过程中骨骼材料特性的改变,一种新的非典型 VI 型成骨不全症模型

Hedjazi, Ghazal; Guterman-Ram, Gali; Blouin, Stéphane; Schemenz, Victoria; Wagermaier, Wolfgang; Fratzl, Peter; Hartmann, Markus A; Zwerina, Jochen; Fratzl-Zelman, Nadja; Marini, Joan C

Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients

血清学SARS-CoV-2抗体反应、潜在预测标志物以及BNT162b2 mRNA COVID-19疫苗在血液病和肿瘤患者中的安全性

Benda, Magdalena; Mutschlechner, Beatrix; Ulmer, Hanno; Grabher, Claudia; Severgnini, Luciano; Volgger, Andreas; Reimann, Patrick; Lang, Theresia; Atzl, Michele; Huynh, Minh; Gasser, Klaus; Petrausch, Ulf; Fraunberger, Peter; Hartmann, Bernd; Winder, Thomas

Development and Evaluation of an Improved Apparatus for Measuring the Emissivity at High Temperatures

高温下发射率测量改进装置的研制与评价

Arduini, Mariacarla; Manara, Jochen; Stark, Thomas; Ebert, Hans-Peter; Hartmann, Jürgen

Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage

非奈利酮联合恩格列净治疗高血压诱导终末器官损伤模型的效果

Kolkhof, Peter; Hartmann, Elke; Freyberger, Alexius; Pavkovic, Mira; Mathar, Ilka; Sandner, Peter; Droebner, Karoline; Joseph, Amer; Hüser, Jörg; Eitner, Frank